INC Research Integrates DrugDev's SiteCloud Platform

April 24, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

INC Research announced a strategic collaboration with DrugDev to complete integration with and implementation of DrugDev’s SiteCloud platform.

INC Research announced a strategic collaboration with DrugDev to complete integration with and implementation of DrugDev’s SiteCloud platform. The SiteCloud platform is the same technology used by TransCelerate’s Investigator Registry and the Investigator Databank. Using  a universal identifier within the platform allows INC to match data from numerous disparate sources--such as its internal experience, the DrugDev Network of 80,000 opted-in global investigators across 115 countries and trusted third-party resources--to create a virtual private database for INC with site and investigator profiles that will be used to make evidence-based decisions.

 

Read the full release.

Related Content:

News